Our Mission
Longstanding Commitment to Tuberculosis
Lionex is dedicated to the cause of Tuberculosis since 27 years. Over nearly three decades, the company has built deep expertise in mycobacterial research and diagnostics. We offer a comprehensive portfolio including IGRA tests, ELISA kits, rapid lateral flow assays, and highly purified antigens. Our solutions support early detection, research, and public health efforts against TB and related diseases globally.
Visionary Biotechnology from Germany
We are a creative biotechnology company specializing in diagnostics and research solutions for infectious diseases. State-of-the-art facilities and ISO-certified quality management systems ensure industry-leading standard for all of our in-vitro diagnostic products and research reagents. Headquartered in Braunschweig, Germany, we serve customers and partners worldwide.
Partnering for Global Health Impact
Lionex collaborates internationally with companies, research institutions, universities, hospitals, and global health organizations. Through strong partnerships and continuous innovation, Lionex delivers essential tools for diagnostics, vaccine development, and therapeutic research, driving progress and improving health outcomes.